Literature DB >> 20557989

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

Lesley A Stevens1, Christopher H Schmid, Tom Greene, Yaping Lucy Zhang, Gerald J Beck, Marc Froissart, Lee L Hamm, Julia B Lewis, Michael Mauer, Gerjan J Navis, Michael W Steffes, Paul W Eggers, Josef Coresh, Andrew S Levey.   

Abstract

BACKGROUND: The Modification of Diet in Renal Disease (MDRD) Study equation underestimates measured glomerular filtration rate (GFR) at levels>60 mL/min/1.73 m2, with variable accuracy among subgroups; consequently, estimated GFR (eGFR)>or=60 mL/min/1.73 m2 is not reported by clinical laboratories. Here, performance of a more accurate GFR-estimating equation, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, is reported by level of GFR and clinical characteristics. STUDY
DESIGN: Test of diagnostic accuracy. SETTING & PARTICIPANTS: Pooled data set of 3,896 people from 16 studies with measured GFR (not used for the development of either equation). Subgroups were defined by eGFR, age, sex, race, diabetes, prior solid-organ transplant, and body mass index. INDEX TESTS: eGFR from the CKD-EPI and MDRD Study equations and standardized serum creatinine. REFERENCE TEST: Measured GFR using urinary or plasma clearance of exogenous filtration markers.
RESULTS: Mean measured GFR was 68+/-36 (SD) mL/min/1.73 m2. For eGFR<30 mL/min/1.73 m2, both equations have similar bias (median difference compared with measured GFR). For eGFR of 30-59 mL/min/1.73 m2, bias was decreased from 4.9 to 2.1 mL/min/1.73 m2 (57% improvement). For eGFR of 60-89 mL/min/1.73 m2, bias was decreased from 11.9 to 4.2 mL/min/1.73 m2 (61% improvement). For eGFR of 90-119 mL/min/1.73 m2, bias was decreased from 10.0 to 1.9 mL/min/1.73 m2 (75% improvement). Similar or improved performance was noted for most subgroups with eGFR<90 mL/min/1.73 m2, other than body mass index<20 kg/m2, with greater variation noted for some subgroups with eGFR>or=90 mL/min/1.73 m2. LIMITATIONS: Limited number of elderly people and racial and ethnic minorities with measured GFR.
CONCLUSIONS: The CKD-EPI equation is more accurate than the MDRD Study equation overall and across most subgroups. In contrast to the MDRD Study equation, eGFR>or=60 mL/min/1.73 m2 can be reported using the CKD-EPI equation. Copyright (c) 2010 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20557989      PMCID: PMC2926290          DOI: 10.1053/j.ajkd.2010.03.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  47 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Predictors of target organ damage in hypertensive blacks and whites.

Authors:  A H El-Gharbawy; J M Kotchen; C E Grim; M Kaldunski; R G Hoffmann; Z Pausova; D Gaudet; F Gossard; P Hamet; T A Kotchen
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

3.  Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

Authors:  Peter Jacobsen; Steen Andersen; Kasper Rossing; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

Authors:  Peter Jacobsen; Steen Andersen; Kasper Rossing; Birgitte V Hansen; Hans-Henrik Parving
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

5.  The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants.

Authors:  Michael Mauer; Keith Drummond
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

6.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

7.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Authors:  Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

8.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

Review 9.  Evaluating the performance of equations for estimating glomerular filtration rate.

Authors:  Lesley A Stevens; Yaping Zhang; Christopher H Schmid
Journal:  J Nephrol       Date:  2008 Nov-Dec       Impact factor: 3.902

10.  Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

Authors:  Henrik Post Hansen; Ellis Tauber-Lassen; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  199 in total

1.  Racial differences in the incidence of chronic kidney disease.

Authors:  Paul Muntner; Britt Newsome; Holly Kramer; Carmen A Peralta; Yongin Kim; David R Jacobs; Catarina I Kiefe; Cora E Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Chronic kidney disease: High eGFR and mortality: high true GFR or a marker of frailty?

Authors:  Shani Shastri; Mark J Sarnak
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study.

Authors:  Myra A Carpenter; Matthew R Weir; Deborah B Adey; Andrew A House; Andrew G Bostom; John W Kusek
Journal:  Clin Transplant       Date:  2012-07-09       Impact factor: 2.863

4.  Periodontitis associated with chronic kidney disease among Mexican Americans.

Authors:  Effie Ioannidou; Yoshio Hall; Helen Swede; Jonathan Himmelfarb
Journal:  J Public Health Dent       Date:  2012-07-06       Impact factor: 1.821

5.  Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.

Authors:  Monique E Cho; Mary H Branton; David A Smith; Linda Bartlett; Lilian Howard; James C Reynolds; Donald Rosenstein; Sanjeev Sethi; M Berenice Nava; Laura Barisoni; Fernando C Fervenza; Jeffrey B Kopp
Journal:  Am J Nephrol       Date:  2019-04-09       Impact factor: 3.754

6.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

7.  Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.

Authors:  Juan Jesus Carrero; Marco Trevisan; Manish M Sood; Peter Bárány; Hong Xu; Marie Evans; Leif Friberg; Karolina Szummer
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-20       Impact factor: 8.237

8.  The impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy.

Authors:  Kyle A Richards; Edris Negron; Joshua A Cohn; Zoe Steinberg; Scott E Eggener; Arieh L Shalhav
Journal:  J Endourol       Date:  2014-08-21       Impact factor: 2.942

9.  Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.

Authors:  Nawar M Shara; Hong Wang; Mihriye Mete; Yaman Rai Al-Balha; Nameer Azalddin; Elisa T Lee; Nora Franceschini; Stacey E Jolly; Barbara V Howard; Jason G Umans
Journal:  Am J Kidney Dis       Date:  2012-07-25       Impact factor: 8.860

10.  Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.

Authors:  Lesley A Inker; Christina Wyatt; Rebecca Creamer; James Hellinger; Matthew Hotta; Maia Leppo; Andrew S Levey; Aghogho Okparavero; Hiba Graham; Karen Savage; Christopher H Schmid; Hocine Tighiouart; Fran Wallach; Zipporah Krishnasami
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.